Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Nuclear Export of mRNA02:31

Nuclear Export of mRNA

7.9K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.9K
Initiation of Translation02:33

Initiation of Translation

34.5K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
34.5K
Regulated mRNA Transport02:22

Regulated mRNA Transport

6.4K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Chemically synthesized, non-capped and non-polyadenylated peptide-coding RNA efficiently induces antigen-specific CD8<sup>+</sup> T cells.

Nature biomedical engineering·2026
Same author

Toward <i>Operando</i> Dynamic Light Scattering During Ultrasonic Dispersion of Nanoparticles.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models.

Nature immunology·2026
Same author

Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.

Nature medicine·2026
Same author

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC.

Nature·2026
Same author

Multiplexed spatial screening of lipid-based nanoparticles for extrahepatic messenger RNA targeting.

Journal of controlled release : official journal of the Controlled Release Society·2026

相关实验视频

Updated: Sep 11, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

紧型聚乙烯胺复合的mRNA疫苗

Jorge Moreno Herrero1, Theo B Stahl1, Stephanie Erbar1

  • 1BioNTech SE, Mainz, Germany.

Nature nanotechnology
|August 11, 2025
PubMed
概括

与聚乙烯胺 (PEI) 复合的新型自我放大RNA (saRNA) 配方显示了增强的疫苗活性. 这些紧的纳米粒子在较低剂量下改善免疫反应,为更广泛的预防和治疗应用提供了潜力.

更多相关视频

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K
Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery
08:09

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery

Published on: August 6, 2019

5.9K

相关实验视频

Last Updated: Sep 11, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K
Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery
08:09

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery

Published on: August 6, 2019

5.9K

科学领域:

  • 生物技术是生物技术.
  • 分子生物学分子生物学
  • 疫苗开发 疫苗开发

背景情况:

  • 自放大RNA (saRNA) 对疫苗和治疗有希望.
  • 之前的saRNA配方在活动和传递方面遇到了挑战.
  • 了解saRNA复杂化是提高疗效的关键.

研究的目的:

  • 开发具有增强生物活性的新型聚合物复杂saRNA配方.
  • 研究这些新配方的结构和功能性质.
  • 评估他们的疫苗接种和遗传物质传递潜力.

主要方法:

  • 单个saRNA分子的配方与阴离子聚合物聚乙烯胺 (PEI).
  • 纳米粒子尺寸,结构和稳定性的表征.
  • 疫苗接种模型中的生物活性和免疫反应的体外和体内评估.

主要成果:

  • PEI复合的saRNA形成了具有高包装密度的紧纳米粒子 (~30nm).
  • 与以前的版本相比,这些配方显示了增强的生物活性.
  • 在疫苗接种模型中,较低剂量可实现相关的免疫反应.
  • 在单分子分数和活性之间发现了直接的相关性.

结论:

  • 新的PEI复杂的saRNA配方为疫苗提供了更好的疗效.
  • 紧的单分子格式对于增强生物活性至关重要.
  • 这些纳米粒子显示出有效的基因材料系统传递的潜力.